Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.04 USD | +3.78% | +6.61% | +201.33% |
May. 08 | Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Treatment of Myotonic Dystrophy Type 1 | MT |
May. 08 | Avidity's Lead Program Gets FDA Breakthrough Designation | DJ |
Business Summary
Number of employees: 253
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody Oligonucleotide Conjugates
100.0
%
| 9 | 100.0 % | 10 | 100.0 % | +3.64% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 9 | 100.0 % | 10 | 100.0 % | +3.64% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Troy Wilson
FOU | Founder | 55 | 12-11-12 |
Sarah Boyce
CEO | Chief Executive Officer | 52 | 19-09-30 |
Michael MacLean
DFI | Director of Finance/CFO | 58 | 20-05-18 |
Steven G. Hughes
CTO | Chief Tech/Sci/R&D Officer | 57 | 22-02-22 |
W. Flanagan
CTO | Chief Tech/Sci/R&D Officer | 62 | 21-01-20 |
Arthur Levin
BRD | Director/Board Member | 70 | 13-09-30 |
Teresa McCarthy
HRO | Human Resources Officer | 60 | 20-07-31 |
Corporate Officer/Principal | - | 21-03-31 | |
Corporate Officer/Principal | 46 | 21-08-24 | |
John W. Wallen
LAW | General Counsel | 66 | 12-11-12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Levin
BRD | Director/Board Member | 70 | 13-09-30 |
Carsten Boess
BRD | Director/Board Member | 57 | 20-04-12 |
Edward Kaye
BRD | Director/Board Member | 74 | 19-08-21 |
Sarah Boyce
CEO | Chief Executive Officer | 52 | 19-09-30 |
Jean J. Kim
BRD | Director/Board Member | 50 | 21-01-10 |
Troy Wilson
FOU | Founder | 55 | 12-11-12 |
Corporate Officer/Principal | 46 | 21-08-24 | |
Noreen Henig
BRD | Director/Board Member | 59 | 19-08-21 |
Tamar Thompson
BRD | Director/Board Member | 50 | 21-01-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 95,624,818 | 89,535,818 ( 93.63 %) | 0 | 93.63 % |
Company contact information
Avidity Biosciences, Inc.
10578 Science Center Drive Suite 125
92121, San Diego
+
http://www.aviditybiosciences.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+201.33% | 2.49B | |
-3.35% | 88.91B | |
+2.76% | 41.25B | |
-14.12% | 31.99B | |
+50.51% | 24.73B | |
-14.95% | 15.54B | |
-39.93% | 12.07B | |
-9.08% | 12.05B | |
-14.91% | 12.02B | |
+6.22% | 8.84B |
- Stock Market
- Equities
- RNA Stock
- Company Avidity Biosciences, Inc.